Amy Sing - Net Worth and Insider Trading
Amy Sing Net Worth
The estimated net worth of Amy Sing is at least $12 Million dollars as of 2024-11-13. Amy Sing is the Sr. Director Medical Affairs of Seagen Inc and owns about 52,107 shares of Seagen Inc (SGEN) stock worth over $12 Million. Details can be seen in Amy Sing's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Amy Sing has not made any transactions after 2003-08-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Amy Sing
Amy Sing Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Amy Sing owns 2 companies in total, including Bio-Path Holdings Inc (BPTH) , and Seagen Inc (SGEN) .
Click here to see the complete history of Amy Sing’s form 4 insider trades.
Insider Ownership Summary of Amy Sing
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BPTH | Bio-Path Holdings Inc | 2017-03-23 | director |
| SGEN | Seagen Inc | 2003-08-18 | Sr. Director Medical Affairs |
Amy Sing Latest Holdings Summary
Amy Sing currently owns a total of 1 stock. Amy Sing owns 52,107 shares of Seagen Inc (SGEN) as of August 18, 2003, with a value of $12 Million.
Latest Holdings of Amy Sing
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGEN | Seagen Inc | 2003-08-18 | 52,107 | 228.74 | 11,918,955 |
Holding Weightings of Amy Sing
Amy Sing Form 4 Trading Tracker
According to the SEC Form 4 filings, Amy Sing has made a total of 0 transactions in Seagen Inc (SGEN) over the past 5 years. The most-recent trade in Seagen Inc is the sale of 20,000 shares on August 18, 2003, which brought Amy Sing around $101,800.
Insider Trading History of Amy Sing
- 1
Amy Sing Trading Performance
Amy Sing Ownership Network
Ownership Network List of Amy Sing
Ownership Network Relation of Amy Sing
Amy Sing Owned Company Details
What does Bio-Path Holdings Inc do?
Who are the key executives at Bio-Path Holdings Inc?
Amy Sing is the director of Bio-Path Holdings Inc. Other key executives at Bio-Path Holdings Inc include director & President & CEO & CFO Peter Henry Nielsen , 10 percent owner Armistice Capital, Llc , and 10 percent owner Armistice Capital Master Fund Ltd. .
Bio-Path Holdings Inc (BPTH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Bio-Path Holdings Inc (BPTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bio-Path Holdings Inc (BPTH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Bio-Path Holdings Inc (BPTH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bio-Path Holdings Inc Insider Transactions
Amy Sing Mailing Address
Above is the net worth, insider trading, and ownership report for Amy Sing. You might contact Amy Sing via mailing address: C/o Saettle Genetics Inc, 21823 30th Drive Se, Bothell Wa 98021.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
